Krebs Biochemicals & Industries Ltd.
NSE: KREBSBIO | BSE: 524518
₹68.14
₹3.24
(4.99%)
As on 27-May-2026IST
Market cap
₹141 Cr
Revenue (TTM)
₹24 Cr
P/E Ratio
--
P/B Ratio
-0.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-17 Cr
-
ROE
0 %
-
ROCE
-29.9 %
-
Industry P/E
36.8
-
EV/EBITDA
-106.8
-
Debt to Equity
-1
-
Book Value
₹-75.7
-
EPS
₹-7.9
-
Face value
10
-
Shares outstanding
21,560,586
10 Years Aggregate
CFO
₹-126.29 Cr
EBITDA
₹-147.33 Cr
Net Profit
₹-243.32 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Krebs Biochemicals
| -1.3 | 14.8 | 13.9 | -6.7 | 3.4 | -13.2 | -- |
|
BSE Healthcare
| 9.3 | 8.8 | 6.8 | 11.3 | 26.4 | 14.0 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Krebs Biochemicals
| -28.8 | 17.3 | -28.5 | -45.5 | 45.2 | 74.9 | -28.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Krebs Biochemicals
|
68.1 | 141.0 | 23.7 | -16.9 | -50.0 | -- | -- | -0.9 |
| 1,070.3 | 13,138.0 | 2,551.8 | 564.5 | 28.3 | 18.4 | 23.3 | 3.9 | |
| 470.3 | 8,160.7 | 947.3 | 247.8 | 28.5 | 18.9 | 32.9 | 6.0 | |
| 1,725.3 | 32,703.0 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35.4 | 6.6 | |
| 432.2 | 4,723.6 | 165.8 | 46.7 | 37.8 | 16.9 | 101.2 | 16.4 | |
| 16,772.0 | 21,502.1 | 2,023.0 | 364.0 | 23.9 | 20.8 | 59.1 | 11.5 | |
| 761.4 | 3,863.0 | 811.3 | 21.0 | 0.7 | 2.1 | 188 | 3.0 | |
| 2,232.6 | 3,705.0 | 707.5 | 115.2 | 17.8 | 19.4 | 32.2 | -- | |
| 1,113.4 | 5,129.2 | 649.5 | 121.6 | 23.7 | 13.2 | 44.5 | 5.5 | |
| 267.2 | 7,038.7 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 11.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Krebs Biochemicals
Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include... androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is based in Visakhapatnam, India. Read more
-
Incorporated
1991
-
Chairman
R T Ravi
-
Managing Director
Manish Jain
-
Headquarters
Vishakhapatnam, Andhra Pradesh
-
Website
Looking for more details about Krebs Biochemicals & Industries Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsResult For FY Ended 31.03.2026
21-May-2026Clarification On Price Movement
10-Apr-2026Results Quarter Ended 31.12.2025
09-Feb-2026No News & Announcements are available.
FAQs for Krebs Biochemicals
What is the current share price of Krebs Biochemicals & Industries Ltd Today?
The share price of Krebs Biochemicals & Industries Ltd is ₹68.14 (NSE) and ₹65.39 (BSE) as of 27-May-2026 IST. Krebs Biochemicals & Industries Ltd has given a return of 3.36% in the last 3 years.
What is the current PB & PE ratio of Krebs Biochemicals & Industries Ltd?
Since, TTM earnings of Krebs Biochemicals & Industries Ltd is negative, P/E ratio is not available.
The P/B ratio of Krebs Biochemicals & Industries Ltd is -0.86 times as on 27-May-2026, a 137 discount to its peers’ median range of 2.30 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
-0.98
|
|
2024
|
0.00
|
-1.10
|
|
2023
|
0.00
|
-1.22
|
|
2022
|
0.00
|
-4.12
|
|
2021
|
0.00
|
-3.72
|
What is the 52 Week High and Low of Krebs Biochemicals & Industries Ltd?
The 52-week high and low of Krebs Biochemicals & Industries Ltd are Rs 113.50 and Rs 38.33 as of 28-May-2026.
What is the market cap of Krebs Biochemicals & Industries Ltd?
Krebs Biochemicals & Industries Ltd has a market capitalisation of ₹ 141 Cr as on 27-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Krebs Biochemicals & Industries Ltd?
Before investing in Krebs Biochemicals & Industries Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.